Plasma Renin Direct
![](https://www.pathkindlabs.com/assets/img/gender-.png)
Gender for Male, Female
![](https://uat.pathkindlabs.com/assets/img/nospr.png)
Patient should be ambulatory / upright 2 hours prior to the test. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be dicontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin levels. Any change in medication should be done in consultation with treating clinician.
![](https://www.pathkindlabs.com/assets/img/sample-.png)
Sample Type
EDTA Plasma
![](https://www.pathkindlabs.com/assets/img/nabl.png)
Labs
![](https://www.pathkindlabs.com/assets/img/trustedbydoctor.png)
Doctors
![](https://www.pathkindlabs.com/assets/img/acureccy-.png)
timely reporting
![](https://www.pathkindlabs.com/assets/img/sample-.png)
of Tests
![](/assets/img/770ffbanner.png)
![callnow](/assets/img/calls.png)